Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 7.0 Contact Hours.
This activity is supported by educational grants from Array BioPharma Inc., Foundation Medicine, Incyte, Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Prometheus Laboratories Inc., and Reata Pharmaceuticals.
The 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a 1-day educational and scientific meeting that will focus on contemporary approaches in the management of melanoma and other cutaneous malignancies, as well as future directions in therapy.
The field of skin cancer treatment has been at the forefront in oncology in recent times, and has been a major focus of novel drug development. In particular, the advent of targeted and immunotherapeutic approaches to manage these malignancies has transformed care, in recent years. There are also many investigational strategies in late-stage development, and these promise to further change practice in 2017. This is great news for patients, but also challenges busy clinicians to maintain state-of-the-art approaches in their practices.
This year’s program, led by world-class experts Omid Hamid, MD and Jeffrey Weber, MD, PhD, will focus on a number of core areas that are key to personalizing care for these tumors in contemporary practices settings, including sessions on immunotherapies, targeted therapies, regional therapy, predictive/prognostic modeling, and integrated medicine/patient care. This fast-paced, highly practical, and interactive forum will once again provide physicians who treat patients with skin cancer unique access to renowned international experts in the management of these tumors.
This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate.
At the conclusion of this symposium, you should be better prepared to:
ONS: PER Forum™: Nursing Opportunities to Improve Outcomes With the Advent of PARP Inhibitors in the Care of Women’s Cancers
May 17, 2018
ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses
May 17, 2018
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of Cancers
May 30, 2018
May 31, 2018
May 31, 2018